Neurology Central

World Alzheimer’s Month 2018 – a thank you from the Editor

September marked World Alzheimer’s Month, where each year the global community comes together to honor those affected by dementia, as well as celebrate the scientists, clinicians, charities and fundraisers working hard to beat this disease. At Neuro Central, we marked this month by organizing a fundraising event, a campaign on #VoicesForDementia, and a Twitter chat (#TalkDementia).

In the lead up to World Alzheimer’s Day (21 September), we organized an in-office virtual fundraising event, where we competed against each other in teams to “walk” from London (UK) to Le Mans (France). After a busy 2 weeks of competing, I’m delighted to announce that we have helped raised £830.61 (£987.01 with Gift Aid) for Alzheimer’s Research UK and the Alzheimer’s Society (both London, UK). We want to say a massive thank you to everyone involved in this fundraising event!

We also want to thank all of our supporters and #VoicesForDementia, who shared a series of responses to a question that we posed, which you can view here. We also wanted to open the discussion to the public and hosted our first ever Twitter chat on the progress and priorities in the dementia field. Some interesting discussions were sparked and we’ve captured the key moments of the chat here. Plus, you can find out more about our panelists by clicking here.

Last month was also filled with a large array of editorial content featuring the dementia field. Take a look at our most recent news and interviews on our World Alzheimer’s Month homepage. This includes air pollution and cognitive decline, gut microbiome alterations in Alzheimer’s disease, and news stories covering the dementia field, such as a new discovery that may shed light on why so many clinical trials for Alzheimer’s fail.

Thank you again for all of your support, and we hope you’ve enjoyed all of our content from the last month!

Best wishes,

Sharon Salt
Editor, Neuro Central

Not yet a member? Sign up to Neuro Central for free and receive exclusive access to all content on the site, as well as all articles in our five partnered journals.